Helix Biopharma (HBPCF) Stock Chart & Stock Price History $0.60 0.00 (0.00%) As of 08/22/2025 Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesBuy This Stock Helix Biopharma Stock Price Performance The Helix Biopharma (HBPCF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 22.63%, with a year-to-date return of 31.90%. In the past month, the stock has remained steady at 0.00%, reflecting recent market activity. As of the latest close, Helix Biopharma traded at $0.60 with a market cap of $44.50 million and volume of 7,650 shares. Five years ago, the stock traded at $0.38, representing a 59.66% increase over that period. At the time, it had a market cap of $49.96 million and a volume of 0 shares. Receive HBPCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month PerformanceN/A3 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year PerformanceN/A5 Year PerformanceN/A HBPCF Stock Chart for Sunday, August, 24, 2025 HBPCF Chart by TradingView Helix Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$0.60$0.60$0.60$0.607,650 shs$44.50 million08/21/2025$0.60$0.60$0.60$0.607,650 shs$44.50 million08/20/2025$0.60$0.60$0.60$0.607,650 shs$44.50 million08/19/2025$0.60$0.60$0.60$0.607,650 shs$44.50 million08/18/2025$0.60$0.60$0.60$0.607,650 shs$44.50 million Related Companies SELLAS Life Sciences Group Stock Chart Tevogen Bio Stock Chart Actuate Therapeutics Stock Chart Sangamo Therapeutics Stock Chart Caribou Biosciences Stock Chart Cellectis Stock Chart Nkarta Stock Chart Nuvectis Pharma Stock Chart BioHarvest Sciences Stock Chart Greenwich LifeSciences Stock Chart Receive HBPCF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Helix Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:HBPCF) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix Biopharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helix Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access